Texas Yale Capital Corp’s Merck MRK Stock Holding History

Texas Yale Capital Corp’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7M	Buy	58,188 +380	+0.7%	+$43.9K	0.2%	74
2025 Q4	$6.08M	Buy	57,808 +325	+0.6%	+$30.5K	0.18%	80
2025 Q3	$4.82M	Buy	57,483 +19,600	+52%	+$1.61M	0.15%	100
2025 Q2	$3M	Buy	37,883 +835	+2%	+$66.4K	0.1%	143
2025 Q1	$3.33M	Sell	37,048 -3,640	-9%	-$340K	0.14%	129
2024 Q4	$4.05M	Buy	40,688 +750	+2%	+$77.3K	0.16%	100
2024 Q3	$4.54M	Sell	39,938 -435	-1%	-$51.7K	0.2%	90
2024 Q2	$5M	Buy	40,373 +465	+1%	+$59.9K	0.24%	73
2024 Q1	$5.27M	Hold	39,908	–	–	0.23%	71
2023 Q4	$4.35M	Hold	39,908	–	–	0.21%	78
2023 Q3	$4.11M	Sell	39,908 -200	-0.5%	-$21.6K	0.19%	73
2023 Q2	$4.63M	Hold	40,108	–	–	0.22%	69
2023 Q1	$4.27M	Hold	40,108	–	–	0.22%	75
2022 Q4	$4.45M	Sell	40,108 -2,300	-5%	-$235K	0.25%	71
2022 Q3	$3.65M	Buy	42,408 +1,035	+3%	+$92.4K	0.23%	81
2022 Q2	$3.77M	Buy	41,373 +820	+2%	+$72.7K	0.24%	81
2022 Q1	$3.33M	Hold	40,553	–	–	0.18%	111
2021 Q4	$3.11M	Buy	40,553 +742	+2%	+$59.1K	0.16%	123
2021 Q3	$2.99M	Buy	39,811 +20	+0.1%	+$1.52K	0.17%	119
2021 Q2	$3.1M	Sell	39,791 -1,553	-4%	-$116K	0.18%	108
2021 Q1	$3.04M	Sell	41,344 -7,231	-15%	-$533K	0.19%	104
2020 Q4	$3.79M	Buy	48,575 +42	+0.1%	+$3.21K	0.25%	77
2020 Q3	$3.84M	Hold	48,533	–	–	0.29%	70
2020 Q2	$3.58M	Sell	48,533 -510	-1%	-$38.4K	0.29%	73
2020 Q1	$3.6M	Buy	49,043 +8,196	+20%	+$644K	0.35%	61
2019 Q4	$3.54M	Buy	40,847 +35	+0.1%	+$2.88K	0.24%	79
2019 Q3	$3.28M	Hold	40,812	–	–	0.24%	86
2019 Q2	$3.27M	Sell	40,812 -39,127	-49%	-$3M	0.24%	86
2019 Q1	$6.34M	Buy	79,939 +41,159	+106%	+$3.08M	0.25%	85
2018 Q4	$2.83M	Buy	38,780 +1,398	+4%	+$98.7K	0.26%	83
2018 Q3	$2.53M	Hold	37,382	–	–	0.2%	100
2018 Q2	$2.17M	Sell	37,382 -1,612	-4%	-$90.9K	0.19%	104
2018 Q1	$2.03M	Buy	38,994 +1,782	+5%	+$96.2K	0.17%	111
2017 Q4	$2M	Sell	37,212 -12,252	-25%	-$679K	0.17%	112
2017 Q3	$3.02M	Sell	49,464 -1,123	-2%	-$68.1K	0.26%	68
2017 Q2	$3.09M	Hold	50,587	–	–	0.27%	62
2017 Q1	$3.07M	Buy	50,587 +1,651	+3%	+$100K	0.27%	63
2016 Q4	$2.75M	Buy	48,936 +16,485	+51%	+$965K	0.26%	70
2016 Q3	$1.93M	Hold	32,451	–	–	0.19%	106
2016 Q2	$1.78M	Sell	32,451 -105	-0.3%	-$5.59K	0.18%	117
2016 Q1	$1.64M	Hold	32,556	–	–	0.17%	116
2015 Q4	$1.64M	Sell	32,556 -996	-3%	-$50.2K	0.16%	119
2015 Q3	$1.58M	Hold	33,552	–	–	0.15%	122
2015 Q2	$1.82M	Hold	33,552	–	–	0.15%	122
2015 Q1	$1.84M	Sell	33,552 -1,155	-3%	-$65.4K	0.15%	119
2014 Q4	$1.88M	Hold	34,707	–	–	0.16%	101
2014 Q3	$1.96M	Buy	34,707 +3,739	+12%	+$210K	0.18%	91
2014 Q2	$1.71M	Hold	30,968	–	–	0.21%	100
2014 Q1	$1.68M	Buy	30,968 +10,899	+54%	+$564K	0.23%	91
2013 Q4	$958K	Hold	20,069	–	–	0.15%	124
2013 Q3	$912K	Buy	20,069 +419	+2%	+$19.1K	0.15%	129
2013 Q2	$871K	Buy	+19,650	New	+$878K	0.15%	129

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Texas Yale Capital Corp's MRK Position: Q1 2026 in Review

Texas Yale Capital Corp increased its Merck (MRK) stake by 0.66% in Q1 2026, buying an estimated $43.9K and bringing the position to 58,188 shares worth $7M. The position accounts for 0.2% of the portfolio, ranked #74.

Texas Yale Capital Corp first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Texas Yale Capital Corp held 58,188 shares of Merck worth $7M as of Q1 2026.
Texas Yale Capital Corp bought 380 Merck shares in Q1 2026, an estimated $43.9K.
Merck made up 0.2% of Texas Yale Capital Corp's portfolio in Q1 2026, its #74 holding.
Texas Yale Capital Corp first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Texas Yale Capital Corp's 13F filing for Q1 2026, filed 4 May 2026.